News Details

HCA to Purchase Mobile Heartbeat

September 6, 2016

HCA (NYSE: HCA), which operates 169 hospitals and 116 freestanding surgery centers in 20 states and the United Kingdom, announced today the signing of an agreement to purchase Mobile Heartbeat, a leading developer of applications for smartphones to improve clinical workflow and team communications. Mobile Heartbeat technology solutions consolidate clinical communications, including alarms and notifications, patient information and lab data, secure texting, voice and photography.

HCA recently completed a successful pilot of Mobile Heartbeat’s CURE™ (Clinical Urgent Response) technology for its iMobile Project, an initiative to implement smartphone-based critical care team communications. Today, HCA is launching Mobile Heartbeat’s CURE technology in 21 hospitals across the country with plans to implement the technology enterprise-wide.

“Mobile Heartbeat is an innovator that is keenly focused on meeting the mobile technology needs of clinicians,” said Dr. Jonathan Perlin, HCA’s chief medical officer and president of the Clinical Services Group. “This acquisition will enhance our ability to work closely with Mobile Heartbeat as we continue to create and refine technology solutions to improve clinical workflows and provide secure communications that foster better patient care.”

Following the completion of the transaction, Mobile Heartbeat’s current chief executive officer Ron Remy will serve as CEO of the organization which will operate as an indirect, wholly owned subsidiary of HCA. Mobile Heartbeat’s team will continue to serve the company’s clients and market its products to leading healthcare organizations from the company’s location in Massachusetts.

“We’ve worked closely with HCA for several years to better understand the challenges clinicians face and to enhance our applications to meet their needs,” said Remy. “Joining HCA will help us serve our current and future customers through a closer collaboration with one of the leading healthcare providers in the world. HCA’s leadership will be instrumental as we continue to develop improved solutions for secure clinical communications.”

HCA expects to complete the transaction before the end of the year. Terms of the agreement are not being disclosed.

Founded in 2009, Mobile Heartbeat provides a highly efficient, patient-specific, clinical team collaboration solution. For more information, visit

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws, which involve risks and uncertainties. Forward-looking statements include statements that do not relate solely to historical or current facts. Forward-looking statements can be identified by the use of words like “may,” “believe,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “initiative” or “continue.” These forward-looking statements are based on our current plans and expectations and are subject to a number of known and unknown uncertainties and risks, many of which are beyond our control, which could significantly affect current plans and expectations and our future financial position and results of operations. These factors include, but are not limited to, the ability to consummate and realize the benefits of the proposed acquisition as well as the risk factors described in our annual report on Form 10-K for the year ended December 31, 2015 and our other filings with the Securities and Exchange Commission. Many of the factors that will determine our future results are beyond our ability to control or predict. In light of the significant uncertainties inherent in the forward-looking statements contained herein, readers should not place undue reliance on forward-looking statements, which reflect management’s views only as of the date hereof. We undertake no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

All references to “Company” and “HCA” as used throughout this release refer to HCA Holdings, Inc. and its affiliates.

HCA Holdings, Inc.
Investor Contact:
Mark Kimbrough, 615-344-2688
Media Contact:
Ed Fishbough, 615-344-2810